Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
904.15
7.10 (0.79%) Natco Pharma informs about outcome of board meeting
Date: 11-02-2016Natco Pharma has informed that the Board of Directors of the Company at its meeting held on February 11, 2016, have taken on record the Interim CFO S V V N Appa Rao appointed as Chief Financial Officer of the Company.
The above information is a part of company’s filings submitted to BSE.